Drug resistance in Ovarian Cancer:biomarkers and treatments - 19/02/2009

The DROC congress is starting today  at the Service center of the Policlinico Hospital in Modena.

For more information, please visit the congress website: www.ovariancancer.unimore.it
 
Lights and TOC - 11/06/2009

 TOC, Tumor bank Ovarian Cancer Organization is described at the

www.toc-network.de

for info,please visit the website

 
 
LIGHTS announces its first results summary report - 18/02/2010

We aimed at restoring the sensibility to Platinum-based drugs through a direct inhibition of TS without affecting TS-mRNA interaction that leads to TS  protein synthesis modulation/alteration

Thus, novel non-cross resistant chemotherapeutic drugs are urgently needed in this disease.

LIGHTS project can support the discovery of new potential anticancer drugs against cross resistant Pt-based drugs with non-cross resistant profiles.

 For dissemination higlights please visit the following address

http://www.scifar.unimore.it/on-line/Home/Personale/articolo2002005.html

 
info@lights-eu.org
MANAGEMENT
Coordination
Committee
Guest scientists
Participants
OBJECTIVE
Synopsis
Project summary
PARTNERS
WORK PACKAGES
Overview
PROJECT MEETINGS
 
LIGands to interfere with Human TS - LIGHTS is a STREP project within the 6FP. Lights is focused on ovarian cancer and carried
out by a consortium of six partners: University of Modena and Reggio Emilia (I) - University di Paris Sud (FR)
European Media Laboratories (D) - Molecular Discovery (I) - Naxospharma (I) - University of California San Francisco (UCSF)

  
Realized by Newlogic